Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club
Drug Research
Drug Discovery & Development
Return to: PBR Home | Drug Research | Drug Discovery & Development | News
Search Refinements

Drug Discovery & Development News

View news from other Pharmaceutical sectors:
91-105 of 3716 results
Ipsen presents first set of results on Phase III clinical study of Dysport
By PBR Staff Writer
Ipsen has reported the first set of results on Phase III clinical study of Dysport, an injectable form of botulinum toxin type A (BoNT-A), in the treatment of adults suffering from upper limb spasticity at the 8th World Congress for NeuroRehabilitation in Istanbul, Turkey.
Drug Research > Drug Discovery & Development > News
Assembly Pharmaceuticals, BioCrossroads to advance potentially curative therapy for chronic hepatitis b virus
Assembly Pharmaceuticals and BioCrossroads have announced that the BioCrossroads Indiana Seed Fund II has made an investment in Assembly Pharmaceuticals.
Drug Research > Drug Discovery & Development > News
Oricula Therapeutics secures initial funding from University of Washington
Oricula Therapeutics, a biotech company, has announced that it has secured initial funding and licensed intellectual property from University of Washington.
Drug Research > Drug Discovery & Development > News
Spero Therapeutics announces antibiotics collaboration with Roche
By PBR Staff Writer
US-based biopharmaceutical company Spero Therapeutics has announced antibiotics collaboration with Switzerland-based F. Hoffmann-La Roche.
Drug Research > Drug Discovery & Development > News
EMA and TGA strengthen collaboration in area of orphan medicines
The European Medicines Agency (EMA) and Australian Therapeutic Goods Administration (TGA) have announced that they have agreed to share the full assessment reports related to marketing authorizations of orphan medicines, which are intended to treat rare diseases.
Drug Research > Drug Discovery & Development > News
Omeros gets FDA clearance for IND application of thrombotic microangiopathies drug
By PBR Staff Writer
US-based biopharmaceutical Omeros has received clearance from the US Food and Drug Administration (FDA) for its investigational new drug application (IND) to assess its lead human monoclonal antibody OMS721 for the inhibition of complement-mediated thrombotic microangiopathies (TMAs).
Drug Research > Drug Discovery & Development > News
Sun Pharma to acquire Ranbaxy Laboratories for $3.2bn
By PBR Staff Writer
Sun Pharmaceutical has entered into definitive agreement to acquire Ranbaxy Laboratories in an all-stock transaction totalling equity value of $3.2bn.
Drug Research > Drug Discovery & Development > News
AMRI completes acquisition of Cedarburg Pharmaceuticals
Albany Molecular Research (AMRI) has announced that it has completed the previously announced acquisition of Cedarburg Pharmaceuticals.
Drug Research > Drug Discovery & Development > News
FDA accepts filing of The Medicines Company's US biologic license application for fibrocaps hemostatic agent
The Medicines Company has announced that the US Food and Drug Administration (FDA) has accepted the filing of a biologic license application (BLA) for the investigational hemostatic agent Fibrocaps, a dry powder formulation of fibrinogen and thrombin being developed to aid in hemostasis during surgery, where control of mild or moderate bleeding by conventional means is ineffective or impractical.
Drug Research > Drug Discovery & Development > News
Particle Sciences enters into joint development agreement with Actavis
Particle Sciences, a drug delivery Contract Development and Manufacturing Organization (CDMO), has entered into an exclusive agreement with Actavis (ACT), a specialty pharmaceutical company, to develop an unnamed complex generic product.
Drug Research > Drug Discovery & Development > News
AstraZeneca, MRC enter into new drug discovery collaboration
By PBR Staff Writer
AstraZeneca has entered into a strategic collaboration with the UK Medical Research Council (MRC) to create a new center for early drug discovery in Cambridge, UK.
Drug Research > Drug Discovery & Development > News
Cilian and University of Edinburgh develop Malaria vaccine
In collaboration with the University of Edinburgh in Scotland, the biotechnology firm Cilian succeeded to reconstruct an important surface protein of the Malaria parasite.
Drug Research > Drug Discovery & Development > News
Pulmokine receives $1.5m Stage B VITA contract from NHLBI
Pulmokine announced it has been awarded a Stage B Vascular Interventions and Therapeutic Advances (VITA) contract from the National Heart, Lung, and Blood Institute (NHLBI), a division of the National Institutes of Health (NIH).
Drug Research > Drug Discovery & Development > News
Xenon, Genentech to develop new therapeutic targets for treating pain
By PBR Staff Writer
Canada-based Xenon Pharmaceuticals has entered into a new collaboration with Genentech, a member of the Roche Group, to discover and validate new therapeutic targets and mechanisms for treating pain.
Drug Research > Drug Discovery & Development > News
Adaptimmune receives £2.1m grant from Biomedical Catalyst Fund
By PBR Staff Writer
Adaptimmune has received £2.1m grant from the Biomedical Catalyst Fund to advance the development of company’s second engineered T cell therapy program into the clinic in triple negative breast cancer.
Drug Research > Drug Discovery & Development > News
91-105 of 3716 results